QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
NASDAQ:TARS

Tarsus Pharmaceuticals Insider Trades

$22.99
+0.21 (+0.92 %)
(As of 09/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$22.64
$23.23
50-Day Range
$21.45
$26.67
52-Week Range
$15.32
$63.69
Volume13,573 shs
Average Volume47,144 shs
Market Capitalization$473.00 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Buying and Selling Activity

33.08% of Tarsus Pharmaceuticals' shares are owned by company executives, directors and other insiders. Over the past twelve months, insiders at the have sold shares 13 time(s), totalling $18,003,108.15. During the same time, Tarsus Pharmaceuticals insiders have purchased shares 2 time(s), totalling $6,750,000.00. Insiders that have bought shares include Jason E Tester, and Vivo Capital Fund Ix L.P.. Insiders that have sold shares include Aziz Mottiwala, Michael Ackermann, Bobak R. Azamian, Bobak R Azamian, Vivo Capital Ix Llc, Vivo Capital Ix Llc, Vivo Capital Ix Llc, Rtw Investments Lp, and Vivo Capital Ix Llc.
Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter


Tarsus Pharmaceuticals (NASDAQ TARS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/10/2021Aziz MottiwalaInsiderSell2,593$22.15$57,434.9558,203  
9/1/2021Michael AckermannDirectorSell5,833$25.24$147,224.921,221,515  
8/11/2021Bobak R. AzamianCEOSell1,917$25.07$48,059.191,750  
8/11/2021Michael AckermannDirectorSell621$25.15$15,618.151,227,348  
8/9/2021Bobak R AzamianCEOSell827$25.02$20,691.541,750  
8/9/2021Michael AckermannDirectorSell700$25.00$17,500.00  
8/6/2021Michael AckermannDirectorSell3,129$25.00$78,225.00  
8/5/2021Bobak R AzamianCEOSell1,370$25.00$34,250.00  
6/25/2021Vivo Capital Ix, LlcMajor ShareholderSell7,704$29.60$228,038.40  
6/23/2021Vivo Capital Ix, LlcMajor ShareholderSell37,980$29.80$1,131,804.00  
6/21/2021Vivo Capital Ix, LlcMajor ShareholderSell91,620$29.70$2,721,114.00  
5/7/2021Rtw Investments, LpMajor ShareholderSell450,000$29.98$13,491,000.00  
4/14/2021Vivo Capital Ix, LlcMajor ShareholderSell400$30.37$12,148.00  
10/20/2020Jason E TesterDirectorBuy171,875$16.00$2,750,000.00
10/20/2020Vivo Capital Fund Ix, L.P.Major ShareholderBuy250,000$16.00$4,000,000.00
(Data available from 1/1/2013 forward)
speech bubbles
speech bubbles











Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Trade Frequently Asked Questions

Who is on Tarsus Pharmaceuticals's Insider Roster?

The list of insiders at Tarsus Pharmaceuticals includes Aziz Mottiwala, Bobak R Azamian, Jason E Tester, Michael Ackermann, Rtw Investments, Lp, Vivo Capital Fund Ix, L.P., and Vivo Capital Ix, Llc.Learn more on TARS's insiders

What percentage of Tarsus Pharmaceuticals stock is owned by insiders?

33.08% of Tarsus Pharmaceuticals stock is owned by insiders. Learn more on TARS's insider holdings

Which Tarsus Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased Tarsus Pharmaceuticals stock in the last 24 months: Jason E Tester ($2,750,000.00), and Vivo Capital Fund Ix, L.P. ($4,000,000.00).

How much insider buying is happening at Tarsus Pharmaceuticals?

Insiders have purchased a total of 421,875 Tarsus Pharmaceuticals shares in the last 24 months for a total of $6,750,000.00 bought.

Which Tarsus Pharmaceuticals insiders have been selling company stock?

The following insiders have sold Tarsus Pharmaceuticals stock in the last 24 months: Aziz Mottiwala ($57,434.95), Bobak R Azamian ($54,941.54), Michael Ackermann ($258,568.07), Rtw Investments, Lp ($13,491,000.00), and Vivo Capital Ix, Llc ($4,093,104.40).

How much insider selling is happening at Tarsus Pharmaceuticals?

Insiders have sold a total of 604,694 Tarsus Pharmaceuticals shares in the last 24 months for a total of $18,003,108.15 sold.

This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.